Intranasal β-agonist in allergic rhinitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 55, Issue 12, 2000, Pages 1198-

  Holt, S ^a   Suder, A ^a   Dronfield, L ^a   Holt, C ^a   Beasley, R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Allergic rhinitis; Drug therapy; Mast cells

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; FORMOTEROL; SALBUTAMOL;

ALLERGIC RHINITIS; ARTICLE; DRUG EFFECT; DRUG EFFICACY; HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ADRENERGIC BETA-AGONISTS; ADULT; AGED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ETHANOLAMINES; FEMALE; HUMANS; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, SEASONAL;

EID: 0033769578     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00830.x     Document Type: Article

References (3)

1. Allergy
2. Inhibition of the immediate allergic reaction in the nose by the beta-2 adrenostimulant fenoterol
3. Effect of systemic beta-agonist therapy on IgE production in allergic subjects in vivo